Ratings Sasol Limited Nyse

Equities

SSL

US8038663006

Market Closed - Nyse Other stock markets 21:00:02 16/05/2024 BST			5-day change	1st Jan Change
7.39 ^USD	+0.68%		+2.21%	-25.65%

05-13	Sasol Limited Appoints Timothy John Cumming as Non-Executive Director, Effective 1 June 2024	CI
05-02	Sasol Chief Financial Officer Hanre Rossouw to Step Down	MT

Strengths

The company's profit outlook over the next few years is a strong asset.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The stock, which is currently worth 2024 to 0.63 times its sales, is clearly overvalued in comparison with peers.
The company's share price in relation to its net book value makes it look relatively cheap.
This company will be of major interest to investors in search of a high dividend stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Revenue estimates are regularly revised downwards for the current and coming years.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Diversified Chemicals

	1st Jan change	Capi.	ESG Refinitiv
SASOL LIMITED	-25.65%	4.62B	-
SHIN-ETSU CHEMICAL CO., LTD.	+0.22%	75.55B	B
BASF SE	+0.60%	48.15B	A-
DUPONT DE NEMOURS, INC.	+0.83%	32.7B	C
PIDILITE INDUSTRIES LIMITED	+11.16%	18.21B	B
EASTMAN CHEMICAL COMPANY	+11.41%	11.86B	A-
BRENNTAG SE	-16.13%	11.15B	B
SYENSQO SA/NV	+1.43%	11B	-
ASAHI KASEI CORPORATION	-0.72%	9.37B	A-
SRF LIMITED	-8.47%	8.13B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes